Search clinical trials for: Stereotactic Radiotherapy

Total 6468 results

N.N. Petrov National Medical Research Center of...

Recruiting

HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Biochemical Relapse Free Survival | Complications Rates (Erectile Dysfunction, GI, GU Complications)

Russian Federation
M.D. Anderson Cancer Center

Recruiting

NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Recurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma

United States
National Cancer Institute, Naples

Recruiting

PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients With LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells) (PRELUDE-1)

Colorectal Cancer Metastatic

Italy
Lawson Health Research Institute
Academic Medical Organization of Southwestern Ontario

Recruiting

Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment

Non-Small Cell Lung Cancer

Canada
University Health Network, Toronto

Recruiting

StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA)

Cardiac Arrhythmia

Canada
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer

Multiple Primary Lung Cancer
University of Milano Bicocca

Recruiting

ABlative Radiotherapy (for) Unfavorable Prostate Tumors (ABRUPT)

Prostate Cancer

Italy
Chongqing University Cancer Hospital

Recruiting

The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPC

Nasopharyngeal Carcinoma

China
Centre Hospitalier Universitaire Vaudois

Recruiting

CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer

Switzerland
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Lung Small Cell Carcinoma | Recurrent Lung Small Cell Carcinoma

United States, Canada
Chang Gung Memorial Hospital

Recruiting

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT (HF-SRT)

Brain Metastases, Adult

Taiwan
Baptist Health South Florida

Recruiting

Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column (DESSRT)

Spine Metastases | Metastasis Spine

United States
University of Texas Southwestern Medical Center

Recruiting

Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC

Non Small Cell Lung Cancer

United States
Azienda Ospedaliero-Universitaria Careggi

Recruiting

Stereotactic Radiotherapy in Association With Immunotherapy for the Treatment of NSCLC Brain Metastases (STRAITLUC)

Brain Metastases From NSCLC

Italy
University Hospital Ostrava

Recruiting

Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Czechia
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Recurrent Glioblastoma | Diffuse Astrocytoma, IDH-Wildtype

United States
Lund University Hospital

Recruiting

Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of Central Nervous System (CNS) Metastases

Brain Metastases | Radiotherapy | Sensitivity | Radionecrosis

Sweden
Centre Hospitalier Universitaire Vaudois

Recruiting

Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung Cancer

Lung Cancer | Lung Metastases | Radiotherapy

Switzerland
Cancer Institute and Hospital, Chinese Academy...
Shanxi Province Cancer Hospital; Wuhan University; Peking Union Medical College... and other collaborators

Recruiting

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Breast Cancer Metastatic

China
University Hospital, Ghent

Recruiting

Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer (DART)

Prostate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Oligometastasis

Belgium
Fudan University

Not yet recruiting

The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal Cancer

Oligometastatic Gastrointestinal Cancer

China
British Columbia Cancer Agency

Recruiting

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) (PROMPT)

Oligometastatic Prostate Cancer

Canada
Changhai Hospital

Recruiting

Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

Treatment

China
Changhai Hospital

Recruiting

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer

Treatment

China
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Metastatic Renal Cell Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Stage IV Lung Cancer AJCC v8 | Stage IV Renal Cell... and other conditions

United States
University of Zurich

Not yet recruiting

Adaptive MR-guided SBRT for Localized Prostate Cancer

Prostate Cancer
Jason J. Luke, MD
Bristol-Myers Squibb

Recruiting

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors

Melanoma | Carcinoma, Renal Cell | Unresectable Solid Tumors

United States
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer (GABRINOX-ART)

Locally Advanced Pancreatic Adenocarcinoma

France
Linda Chan, MD

Recruiting

TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer

Prostate Cancer

United States
West China Hospital

Recruiting

Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC

Immunotherapy | SBRT | Stage IV HCC

China
Fudan University

Recruiting

The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer

Colorectal Cancer

China
David Büchser

Recruiting

HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer (BRAchySABR)

Prostatic Neoplasm

Spain
European Organisation for Research and Treatment...
Anticancer Fund, Belgium; Rising Tide Foundation

Recruiting

Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) (OligoRARE)

Melanoma | Sarcoma | Head and Neck Cancer | Gynecologic Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Bladder Cancer | Skin Cancer | Colon Cancer | Renal Cancer | Oligometastasis | Hepatobiliary Cancer | Upper Urinary Tract Carcinoma

Italy, France, Belgium, Switzerland, United Kingdom, Poland, Germany
King Hussein Cancer Center

Recruiting

SBRT for Breast Cancer Oligometastases

Breast Neoplasm Malignant Female

Jordan
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8

United States
Centre hospitalier de l'Université de Montréal...

Recruiting

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer (SUPPRESS-NSCLC)

Lung Cancer Metastatic

Canada
Universitaire Ziekenhuizen KU Leuven

Recruiting

Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases (LAT-MUM)

Brain Metastases, Adult

Belgium
Cancer Trials Ireland
University College Dublin; Technological University Dublin

Recruiting

'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung) (SOURCE Lung)

NSCLC/Oligometastatic Cancer (Single Lung Lesion)

Ireland
GT Medical Technologies, Inc.

Recruiting

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Brain Metastases

United States
University of Miami

Recruiting

SABER Study for Selected Early Stage Breast Cancer (SABER)

Breast Cancer | Early-stage Breast Cancer

United States
Washington University School of Medicine
National Cancer Institute (NCI); Verastem, Inc.

Recruiting

Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma

Pancreas Adenocarcinoma | Pancreas Cancer | Cancer of the Pancreas

United States
University Medical Center Groningen
Dutch Cancer Society

Recruiting

Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (ADOPT)

Prostate Cancer

Netherlands
Centre Francois Baclesse
National Cancer Institute, France; GETUG

Recruiting

Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases (GETUG-StORM-01)

Metastatic Renal Cell Carcinoma | Radiotherapy

France
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Recruiting

Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8

United States
Zhejiang Cancer Hospital

Not yet recruiting

Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung
Yale University

Recruiting

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

Non-small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center
Janssen Scientific Affairs, LLC

Recruiting

A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS)

Prostate Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Hematopoietic and Lymphoid Cell Neoplasm | Allogeneic Hematopoietic Stem Cell Transplant Recipient

United States
Centre hospitalier de l'Université de Montréal...
M.D. Anderson Cancer Center; Lawson Health Research Institute; Jewish General...

Recruiting

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer (SHORT-OPC)

Head and Neck Cancer | Oropharynx Cancer | Human Papilloma Virus

Canada
Hamilton Health Sciences Corporation
Juravinski Cancer Centre Foundation

Recruiting

Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief (SOLAR-P)

Melanoma | Renal Cell Carcinoma | Breast Cancer | Prostate Cancer | Bone Metastases

Canada

Search clinical trials for: Stereotactic Radiotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations